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http://www.biomedcentral.com/1471-2458/12/281RESEARCH ARTICLE Open AccessMortality after admission for acute myocardial
infarction in Aboriginal and non-Aboriginal
people in New South Wales, Australia: a multilevel
data linkage study
Deborah A Randall1*, Louisa R Jorm1,2, Sanja Lujic1, Aiden J O’Loughlin1, Timothy R Churches2, Mary M Haines2,
Sandra J Eades3 and Alastair H Leyland4Abstract
Background: Heart disease is a leading cause of the gap in burden of disease between Aboriginal and non-
Aboriginal Australians. Our study investigated short- and long-term mortality after admission for Aboriginal and
non-Aboriginal people admitted with acute myocardial infarction (AMI) to public hospitals in New South Wales,
Australia, and examined the impact of the hospital of admission on outcomes.
Methods: Admission records were linked to mortality records for 60047 patients aged 25–84 years admitted with a
diagnosis of AMI between July 2001 and December 2008. Multilevel logistic regression was used to estimate
adjusted odds ratios (AOR) for 30- and 365-day all-cause mortality.
Results: Aboriginal patients admitted with an AMI were younger than non-Aboriginal patients, and more likely to
be admitted to lower volume, remote hospitals without on-site angiography. Adjusting for age, sex, year and
hospital, Aboriginal patients had a similar 30-day mortality risk to non-Aboriginal patients (AOR: 1.07; 95% CI 0.83-
1.37) but a higher risk of dying within 365 days (AOR: 1.34; 95% CI 1.10-1.63). The latter difference did not persist
after adjustment for comorbid conditions (AOR: 1.12; 95% CI 0.91-1.38). Patients admitted to more remote hospitals,
those with lower patient volume and those without on-site angiography had increased risk of short and long-term
mortality regardless of Aboriginal status.
Conclusions: Improving access to larger hospitals and those with specialist cardiac facilities could improve
outcomes following AMI for all patients. However, major efforts to boost primary and secondary prevention of AMI
are required to reduce the mortality gap between Aboriginal and non-Aboriginal people.
Keywords: Hospital performance, Acute myocardial infarction, Ischaemic heart disease, Aboriginal health, Health
outcomes, Multilevel modelling, Data linkageBackground
The health of Aboriginal and Torres Strait Islander Aus-
tralians is worse than that of other Australians across
every conceivable health indicator [1]. The determinants
of the disproportionate ill-health among Aboriginal
people include higher levels of behavioural, biomedical
and psychosocial risk factors, in combination with lesser* Correspondence: d.randall@uws.edu.au
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reproduction in any medium, provided the oraccess to appropriate health services and lower socio-
economic status (SES) [1-5].
While the determinants are complex, the results are
clear – Aboriginal Australians have a burden of disease
which is two-and-a-half times that of non-Aboriginal
Australians [1], and an estimated gap in life expectancy
that is greater than that in other developed countries [6].
Ischaemic heart disease (IHD) accounts for 14% of the
gap in burden of disease [2], and Aboriginal Australians
have higher age-adjusted rates of incidence, hospital ad-
mission and mortality for acute myocardial infarctionLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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studies have compared rates of invasive interventions
[7,9-11], none has quantified the impact of hospital care
on variations in short-term and long-term outcomes for
Aboriginal and non-Aboriginal people after admission
for AMI.
This study investigated short- and long-term mortality
after admission for Aboriginal and non-Aboriginal resi-
dents of New South Wales (NSW) admitted to hospital
with AMI and also investigated the impact of hospital of
admission on outcomes.
Methods
Study design
Observational cohort study using linked hospital and
mortality data.
Data sources
The NSW Admitted Patients Data Collection (APDC)
includes records for all NSW public and private hospital
separations (hospital admissions ending in a discharge,
transfer, type-change or death). Patient demographics
and multiple diagnoses and procedures are recorded for
each separation and coded according to the Australian
modification of the International Statistical Classification
of Diseases and Related Problems (diagnoses) and the
Australian Classification of Health Interventions (proce-
dures) [12]. The NSW Register of Births, Deaths and
Marriages (RBDM) captures details of all deaths regis-
tered in NSW.
Probabilistic linkage
The APDC from 1 July 2000 to 31 December 2008 was
linked with the RBDM from 1 July 2000 to 31 December
2009. Personal identifiers (including full name, date of
birth, sex and address) from the datasets were linked
using probabilistic methods by the Centre for Health
Record Linkage [13]. The researchers were supplied with
de-identified APDC and RBDM data and merged these
using a project-specific unique person number.
Setting
NSW is the most populous state in Australia with an
estimated 6.8 million residents in 2006, 2.2% who iden-
tify as Aboriginal and/or Torres Strait Islander [14]. Ap-
proximately 30% of Australia’s Aboriginal peoples live in
NSW, the largest percentage of all the States and Terri-
tories in Australia. In 2006, 73% of the total NSW popu-
lation lived in a major city [15] compared with 42% of
the NSW Aboriginal population [16]. The median age of
Aboriginal people in NSW in 2006 was 20.6 years [17]
while the median age for non-Aboriginal people was
38.6 years [18].Participants
The participants were NSW residents aged 25 to 84 who
were admitted to a public hospital with a primary diag-
nosis of acute myocardial infarction (AMI, ICD-10-AM
code ‘I21’) or ischaemic heart disease (IHD, ICD-10-AM
codes ‘I20’-‘I25’) with a diagnosis of AMI in the second
or third diagnosis fields, and where the admission was
classified as both ‘acute care’ and ‘emergency’. Only first
admissions to public hospitals were included, because
the linkage for private hospitals was not of the same
quality as for public hospitals. The first such admission
in the period July 2001 to December 2008 was chosen as
the index admission for analysis, with at least a one-year
clearance period for previous admissions for AMI. The
cohort thus consisted of cases whose index admission
was their first-ever as well as those who had an AMI ad-
mission prior to July 2000. A sensitivity analysis exclud-
ing previously-admitted cases with clearance periods of
between one and four years found no significant differ-
ence in the Aboriginal to non-Aboriginal 30-day and
365-day mortality ratios. Patients were excluded if they
had missing data or appeared to be duplicate admissions
(244 non-Aboriginal and 3 Aboriginal records). The
excluded records had the same percentage of deaths
within 30 days as the final data set (9%). The final data
set included 60047 patients (1183 Aboriginal, 58864
non-Aboriginal) admitted to 174 public hospitals in
NSW.
Analysis variables
The main outcomes were 30-day and 365-day all-cause
mortality after hospital admission. The main variable of
interest was whether the patient identified as Aboriginal.
This was determined based on the standard question,
“Are you of Aboriginal or Torres Strait Islander origin?”,
recorded in the hospital data. In 2007, an audit was con-
ducted and the percentage of Aboriginal and Torres
Strait Islander patients correctly identified in NSW pub-
lic hospitals was estimated to be 88% [19]. While identi-
fication is thought to have improved over time, there
were no audits previously published for NSW [20]. How-
ever, the Australian Institute of Health and Welfare used
an under-identification factor of 30% to correct expend-
iture data for 1998–99 and 2001–02 for NSW hospital
data [20]. Probabilistic linkage provided opportunities
for identification across the entire admission history for
each individual but in the absence of an external source
of Aboriginal status to validate identification algorithms,
we defined Aboriginal people in our study (Aboriginal
and/or Torres Strait Islander) based on the most recent
public hospital admission recorded for each person. This
was thought to be the most accurate method due to
improvements in identification over time [19,20]. A sen-
sitivity analysis was carried out using two alternative
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(‘all admissions’) or on at least one admission (‘ever
identified’).
Comorbidities were measured with the Ontario AMI
mortality prediction rule (OAMIMPR) [21] conditions,
developed in Ontario, Canada for risk adjustment specif-
ically after AMI admission, and were supplemented with
additional Charlson Comorbidity Index conditions [22]
that had a significant age-, sex- and year-adjusted associ-
ation with 30-day or 365-day mortality. All comorbidities
were collected with a one-year look-back that included
any comorbid conditions recorded on the APDC for each
person for a full year before the AMI admission as well as
on the admission record. Socio-economic status was clas-
sified using the ABS Socio-Economic Index for Areas
Index of Relative Social Disadvantage (SEIFA IRSD) based
on Statistical Local Area (SLA) of residence, and divided
into population quintile groups. Remoteness of residence
was ascertained using the Accessibility/Remoteness Index
of Australia (ARIA+) for SLA of residence, grouped into
four categories (major city, inner regional, outer re-
gional and remote/very remote). The hospital of ana-
lysis was the first hospital of admission in the AMI
admission episode. There were three hospital-level
variables: hospital remoteness (ARIA + group of the
hospital based on postcode), hospital size (the average
number of all acute admissions per year between
2001 and 2008, calculated for each hospital and
divided into five groups at the 50th, 75th, 85th and
95th percentiles for hospitals), and the presence or
absence of on-site cardiac angiography facilities.
Statistical analysis
Characteristics of Aboriginal and non-Aboriginal people
admitted with AMI were compared using χ2 tests.
Comorbidities were additionally compared using age-,
sex- and year-adjusted prevalence ratios calculated using
a log-Poisson model. A series of multilevel logistic re-
gression models with 60047 AMI patients clustered
within 174 hospitals investigated: the relative odds of 30-
day and 365-day mortality after admission for Aboriginal
people compared with non-Aboriginal people with step-
wise adjustment of individual and hospital factors; how
much of the variation in mortality related to the hospital
of admission; what individual characteristics are asso-
ciated with 30-day and 365-day mortality; and what hos-
pital characteristics might explain residual variation
between hospitals. The number of AMI patients per hos-
pital in the final models ranged from 1 to 2691, with a
median of 65. Only 5% of hospitals had two or fewer
patients. Multilevel modelling accounts for the cluster-
ing of patients within hospitals and also partitions the
residual variation into the between-hospital variation
and within-hospital variation [23]. All multilevel modelshad a random intercept allowing the hospital mortality
rate to vary, and we also tested random slope models to
see if the odds ratio for Aboriginal status varied between
hospitals. The hospital-level variance can be expressed
as a percentage of the total variance, also called the
intraclass correlation coefficient (ICC), or can be con-
verted into a median odds ratio (MOR), which is the
median of the odds ratios of pair-wise comparisons of
patients with identical characteristics taken from ran-
domly chosen hospitals [24]. Data analyses were carried
out using SAS 9.1.3 [25] and MLwiN 2.22 [26].
Ethics approval
Approval for the study was given by the NSW Popula-
tion and Health Services Research Ethics Committee,
the Aboriginal Health and Medical Research Council of
NSW Ethics Committee, and the University of Western
Sydney Human Research Ethics Committee.
Results
Patient characteristics
Aboriginal patients with AMI were significantly younger
than non-Aboriginal patients with just over half of the
Aboriginal patients aged 25–54 years compared with
only one-fifth of non-Aboriginal patients (Table 1). Abo-
riginal patients were also more likely to be female, more
likely to be living in an area classified as most disadvan-
taged, and more likely to be living in an outer regional
or remote area. Aboriginal patients were significantly
less likely to be admitted to a major city hospital, a hos-
pital with 18400 or more average acute admissions per
year, or one with on-site angiography facilities. Due to
the marked demographic differences, age-, sex- and
year-adjusted prevalence ratios were calculated to com-
pare the prevalence of comorbidities. These showed that
Aboriginal patients were more likely than non-Aborigi-
nal patients of the same age, sex and year of admission
to have acute and chronic renal failure, paraplegia, con-
gestive heart failure, diabetes with complications, and
pulmonary disease (Figure 1).
Short- and long-term mortality after admission
Of the 1183 Aboriginal patients admitted with AMI, 70
died within 30 days of admission (5.9%) and 127 died
within one year of admission (10.7%). Of the 58864 non-
Aboriginal patients admitted with AMI, 5474 died
within 30 days (9.3%) and 9148 died within one year
(15.2%). When accounting only for hospital of admission
through the random intercept multilevel model, Aborigi-
nal patients with AMI had lower odds of dying within
30 days than non-Aboriginal patients (odds ratio (OR)
0.61; 95% CI 0.48-0.78; Table 2, Model 1A). However,
after adjusting for age, sex and year of admission there
was no significant difference in 30-day mortality
Table 1 Individual and hospital characteristics of
Aboriginal and non-Aboriginal people admitted with
acute myocardial infarction
Aboriginal
(n = 1183)
Non-
Aboriginal
(n = 58877)
χ2
p-value
N % N %
Individual characteristic
Age group
25-34 47 4.0 421 0.7 <.001
35-44 257 21.7 2829 4.8
45-54 360 30.4 8579 14.6
55-64 265 22.4 13144 22.3
65-74 180 15.2 15410 26.2
75-84 74 6.3 18481 31.4
Sex
Male 727 61.5 39950 67.9 <.001
Female 456 38.5 18914 32.1
Comorbid conditionsa
Diabetes with
complications
279 23.6 8903 15.1 <.001
Cardiac dysrhythmias 185 15.6 12539 21.3 <.001
Congestive heart failure 154 13.0 8350 14.2 .254
Pulmonary disease 136 11.5 5236 8.9 .002
Chronic renal failure 96 8.1 4143 7.0 .152
Acute renal failure 47 4.0 2729 4.6 .282
Cerebrovascular
disease
36 3.0 2552 4.3 .030
Paraplegia 25 2.1 1341 2.3 .707
Cancer 15 1.3 1773 3.0 0.01
Peripheral vascular
disease
12 1.0 1108 1.9 .029
Shock 11 0.9 1195 2.0 .008
Pulmonary oedema 9 0.8 685 1.2 .199
Connective tissue
disorder
8 0.7 743 1.3 .073
Dementia 5 0.4 506 0.9 .105
Severe liver disease 2 0.2 103 0.2 .962
Liver disease 1 0.1 113 0.2 .615
Socio-economic statusb
1st quintile - least
disadvantaged
23 1.9 7832 13.3 <.001
2nd quintile 109 9.2 9946 16.9
3rd quintile 186 15.7 12726 21.6
4th quintile 299 25.3 13102 22.3
5th quintile - most
disadvantaged
566 47.8 15258 25.9
Table 1 Individual and hospital characteristics of
Aboriginal and non-Aboriginal people admitted with
acute myocardial infarction (Continued)
Remoteness of residencec
Major city 307 26.0 34695 58.9 <.001
Inner regional 359 30.3 16319 27.7
Outer regional 366 30.9 7300 12.4
Remote/very remote 151 12.8 550 0.9
Hospital characteristic
Remoteness of hospitalc
Major city 389 32.9 39456 67.0 <.001
Inner regional 247 20.9 11384 19.3
Outer regional 414 35.0 7297 12.4
Remote/very remote 133 11.2 726 1.2
Average acute admissions per year
Less than 1200 88 7.4 1245 2.1 <.001
1200-3899 182 15.4 3730 6.3
3900-7084 138 11.7 3842 6.5
7085-18399 443 37.4 19977 33.9
18400 or more 332 28.1 30070 51.1
On-site angiography
Yes 315 26.6 25694 43.6 <.001
No 868 73.4 33170 56.4
a Comorbid conditions with one-year look-back, including comorbidities on
current admission and any admissions in the previous year.
b Socio-Economic Indices for Areas (SEIFA) Index of Relative Socio-Economic
Disadvantage population quintiles based on statistical local area of residence.
c Accessibility/Remoteness Index of Australia (ARIA+) based on statistical local
area of residence for individuals or hospital postcode for hospitals.
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(AOR 1.07; 95% CI 0.83-1.37; Model 2A). Accounting
for comorbidities, remoteness of residence, and socio-
economic status (Model 5A) reduced the adjusted odds
ratio to 0.95 (0.73-1.23), indicating no significant differ-
ence in 30-day mortality. A random slope effect for Abo-
riginal status was tested, but there was no significant
variation in the Aboriginal to non-Aboriginal 30-day
mortality ratio across hospitals.
The unadjusted results for 365-day mortality were
similar to the 30-day model: Aboriginal patients were
less likely to die within 365 days of admission than non-
Aboriginal patients admitted to the same hospital (OR
0.64; 95% CI 0.53-0.77; Table 2, Model 1B). However,
after adjusting for age, sex, and year of admission, Abori-
ginal patients had significantly higher odds of dying
within 365 days than non-Aboriginal patients admitted
to the same hospital (AOR 1.34, 95% CI 1.10-1.63;
Model 2B). Again, there was no random slope effect for
Aboriginal status in this model. After comorbidities were
accounted for there was no longer a significant
0.5
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Figure 1 Relative adjusted prevalence of comorbidities for Aboriginal compared with non-Aboriginal people with AMI.Prevalence ratio
adjusted for age, sex and year of admission, for Aboriginal compared with non-Aboriginal people with AMI. A value over 1 indicates that
Aboriginal people have a higher prevalence of the condition, and a value under 1 indicates that non-Aboriginal people have a higher prevalence.
Comorbid conditions calculated with one-year look-back, including comorbidities on current admission and any admissions in the previous year.
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day mortality (AOR 1.12, 95% CI 0.91-1.38; Model 3B).
In the fully-adjusted individual-level model for 30-day
mortality (Model 5A), the percentage of unexplained
variation due to the hospital of admission (or the Intra-
class correlation coefficient) was 2.72%. This can be
expressed as a median odds ratio (MOR) of 1.34. In the
fully-adjusted 365-day mortality model (Model 5B), the
hospital of admission accounted for 2.58% of the unex-
plained variation in the outcome (MOR 1.33).
Table 3 shows odds ratios for selected individual cov-
ariates from the fully-adjusted individual-level models
(Models 5A and 5B). There were no significant differ-
ences in 30-day or 365-day mortality between males and
females. Older age was strongly related to both 30-day
and 365-day mortality. Area of residence was not a sig-
nificant predictor of 30-day or 365-day mortality, but re-
moteness was already being largely accounted for by
adjusting for hospital of admission. Living in an area
classified as the most disadvantaged was associated with
higher 30-day mortality, and there was higher 365-day
mortality in all the more disadvantaged quintiles com-
pared with the least disadvantaged group. Of the
comorbidities included in the model, shock was most
strongly related to risk of morality, particularly 30-day
mortality. Severe liver disease, cardiac dysrhythmias, de-
mentia, cancer and acute renal failure were associated
with at least a doubling in the odds of dying within 30and 365 days of admission. Most of the other comor-
bidities were significantly associated with an increased
risk of either 30-day or 365-day mortality. Diabetes with
complications was related to a slightly lower risk of 30-
day mortality but a slightly higher risk of 365-day
mortality.
Table 4 shows the relative odds of 30-day and 365-day
mortality for the hospital characteristics, added one at a
time to the fully adjusted individual-level model. Hospital
remoteness was a significant predictor of both 30-day and
365-day mortality; those patients admitted to an outer re-
gional or a remote hospital had significantly higher odds
of mortality than those admitted to a major city hospital.
Those admitted to hospitals with 7084 or less acute
patients per year had higher odds of both 30-day and 365-
day mortality than those admitted to hospitals with higher
numbers of acute admissions per year and there was a sig-
nificant trend across groups (P< 0.001 for both 30-day
and 365-day models). Those admitted to a hospital with
on-site angiography had lower odds of 30-day and 365-
day mortality than those admitted to a hospital without
these facilities. When all three hospital level variables were
added they accounted for 37% of the hospital level vari-
ation in both the 30-day and 365-day mortality models.
Sensitivity analysis
The two alternative classifications for Aboriginal status,
‘ever identified’ and ‘all admissions’, identified 1479
Table 2 Relative odds of 30-day and 365-day mortality for Aboriginal compared with non-Aboriginal people with
stepwise adjustment for covariates
30-day mortality models
Model Adjusted for: OR 95% CI p-value
1A Hospital of admissiona 0.61 0.48-0.78 <.001
Individual covariates
2A + Age group, sex, year of admission 1.07 0.83-1.37 .612
3A + Comorbid conditionsb 0.98 0.76-1.27 .886
4A + Remoteness of residencec 0.95 0.73-1.24 .728
5A + Socio-economic statusd 0.95 0.73-1.23 .684
Hospital covariatese
6A + Remoteness of hospitalc 0.94 0.72-1.22 .617
7A + Average acute admissions per year (- Remoteness of hospital) 0.95 0.73-1.23 .676
8A + On-site angiography (- Average acute admissions per year) 0.94 0.73-1.23 .665
365-day mortality models
Model Adjusted for: OR 95% CI p-value
1B Hospital of admissiona 0.64 0.53-0.77 <.001
Individual covariates
2B + Age group, sex, year of admission 1.34 1.10-1.63 .003
3B + Comorbid conditionsb 1.12 0.91-1.38 .282
4B + Remoteness of residencec 1.11 0.90-1.37 .317
5B + Socio-economic statusd 1.11 0.90-1.36 .345
Hospital covariatese
6B + Remoteness of hospitalc 1.09 0.89-1.35 .401
7B + Average acute admissions per year (- Remoteness of hospital) 1.11 0.90-1.36 .336
8B + On-site angiography (- Average acute admissions per year) 1.10 0.90-1.36 .350
OR, odds ratio; CI, confidence interval.
a Hospital of admission adjusted for in a two-level random intercept model with patients nested within hospitals.
b Comorbid conditions with one-year look-back, including comorbidities on current admission and any admissions in the previous year.
c Accessibility/Remoteness Index of Australia (ARIA+) based on statistical local area of residence for individuals or hospital postcode for hospitals.
d Socio-Economic Indices for Areas (SEIFA) Index of Relative Socio-Economic Disadvantage population quintiles based on statistical local area of residence.
e Hospital covariates added one at a time to the adjusted models.
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spectively, compared with the ‘most recent’ which iden-
tified 1183 (2.0%) of patients as Aboriginal. When
entered into the fully-adjusted individual-level models,
the ‘ever identified’ definition produced similar results to
the ‘most recent’ definition, but the ‘all admissions’ def-
inition resulted in higher odds of both 30-day and 365-
day mortality for Aboriginal compared with non-Abori-
ginal patients (Table 5).
Discussion
Our study is, to the best of our knowledge, the first to in-
vestigate disparities in mortality outcomes between Abori-
ginal and non-Aboriginal people after admission for AMI
in NSW, home to 30% of Australia’s Aboriginal popula-
tion [14]. The overall population size and the large num-
ber of Aboriginal people residing in NSW made itpossible to use multilevel modelling to examine mortality
outcomes, and it is the first study of AMI hospital out-
comes nationally to account for clustering of patients
within hospitals and to quantify the contribution of the
admitting hospital to variation in mortality outcomes.
Aboriginal and non-Aboriginal people with AMI ad-
mitted to NSW hospitals were very different. Aboriginal
patients were younger, more likely to live outside of
major centres and in disadvantaged areas, and more
likely to be admitted to lower volume hospitals outside
major centres and those without on-site angiography fa-
cilities. After adjusting for age, sex and year, they were
more likely to present with comorbid conditions, includ-
ing acute and chronic renal failure, diabetes, congestive
heart failure and pulmonary disease. Aboriginal people
in Australia have a younger age distribution than non-
Aboriginal people, so it is not unexpected that
Table 3 Adjusted odds ratios for selected individual covariates for 30-day and 365-day mortality multilevel models
30-day mortality 365-day mortality
AOR 95% CI p-value AOR 95% CI p-value
Sex
Male (ref) 1.00 .211 1.00 .853
Female 1.04 0.98-1.11 1.01 0.95-1.06
Age group
25-34 1.20 0.79-1.83 <.001 0.92 0.61-1.37 <.001
35-44 0.73 0.59-0.91 0.58 0.48-0.72
45-54 0.80 0.70-0.92 0.74 0.66-0.83
55-64 (ref) 1.00 1.00
65-74 1.52 1.38-1.68 1.70 1.57-1.85
75-84 2.30 2.10-2.53 3.09 2.86-3.34
Comorbid conditionsa
Shock 11.54 10.12-13.16 <.001 7.94 6.94-9.09 <.001
Severe liver disease 3.80 2.36-6.11 <.001 2.60 1.63-4.17 <.001
Cardiac dysrhythmias 2.69 2.53-2.86 <.001 2.18 2.06-2.30 <.001
Dementia 2.30 1.87-2.84 <.001 2.72 2.25-3.30 <.001
Cancer 2.18 1.92-2.47 <.001 4.45 4.00-4.95 <.001
Acute renal failure 2.02 1.82-2.25 <.001 2.00 1.82-2.19 <.001
Cerebrovascular disease 1.53 1.33-1.77 <.001 1.47 1.29-1.66 <.001
Peripheral vascular disease 1.32 1.11-1.57 <.001 1.30 1.12-1.51 <.001
Pulmonary disease 1.25 1.14-1.37 <.001 1.56 1.45-1.67 <.001
Pulmonary oedema 1.22 0.99-1.51 .056 1.50 1.26-1.80 <.001
Congestive heart failure 1.20 1.12-1.30 <.001 1.81 1.70-1.92 <.001
Paraplegia 1.08 0.89-1.31 .424 1.43 1.21-1.69 <.001
Chronic renal failure 1.06 0.95-1.17 .282 1.56 1.44-1.70 <.001
Liver disease 0.97 0.55-1.69 .913 2.42 1.55-3.79 <.001
Diabetes with complications 0.89 0.82-0.97 .007 1.10 1.03-1.18 .003
Connective tissue disorder 0.81 0.62-1.04 .096 1.18 0.97-1.43 .090
Remoteness of residenceb
Major city (ref) 1.00 .223 1.00 .685
Inner regional 0.95 0.86-1.06 0.95 0.87-1.04
Outer regional 1.08 0.94-1.24 1.00 0.89-1.12
Remote/very remote 1.16 0.84-1.58 0.96 0.73-1.27
Socio-economic statusc
1st quintile - least disadvantaged (ref) 1.00 .033 1.00 <.001
2nd quintile 1.15 0.99-1.32 1.11 0.98-1.25
3rd quintile 1.10 0.95-1.28 1.18 1.04-1.34
4th quintile 1.17 1.00-1.36 1.23 1.08-1.39
5th quintile - most disadvantaged 1.27 1.08-1.48 1.32 1.16-1.51
Adjusted odds ratios for selected covariates from Model 5A for 30-day mortality and Model 5B for 365-day mortality.
AOR, adjusted odds ratio; CI, confidence interval; Ref, referent group in the analysis.
a Comorbid conditions with one-year look-back, including comorbidities on current admission and any admissions in the previous year.
b Accessibility/Remoteness Index of Australia (ARIA+) based on statistical local area of residence.
c Socio-Economic Indices for Areas (SEIFA) Index of Relative Socio-Economic Disadvantage population quintiles based on statistical local area of residence.
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Table 4 Adjusted odds ratios for selected hospital covariates for 30-day and 365-day mortality multilevel models
30-day mortality 365-day mortality
AOR 95% CI p-value AOR 95% CI p-value
Added into adjusteda model separately
Remoteness of hospitalb
Major city (ref) 1.00 <.001 1.00 <.001
Inner regional 1.15 0.94-1.41 1.16 0.97-1.39
Outer regional 1.56 1.26-1.94 1.54 1.27-1.87
Remote/very remote 1.83 1.19-2.81 1.79 1.22-2.61
Average acute admissions per year
Less than 1200 2.03 1.57-2.62 <.001 1.98 1.58-2.49 <.001
1200-3899 1.72 1.39-2.13 1.55 1.28-1.88
3900-7084 1.36 1.08-1.70 1.32 1.07-1.62
7085-18399 1.14 0.96-1.35 1.14 0.97-1.34
18400 or more (ref) 1.00 1.00
On-site angiography
Yes 0.74 0.64-0.86 <.001 0.72 0.63-0.83 <.001
No (ref) 1.00 1.00
AOR, adjusted odds ratios; CI, confidence interval. Ref, referent group in the analysis.
a Adjusted for Aboriginal status, age, sex, year of admission, comorbidities, remoteness of residence, socio-economic status, and a random hospital intercept, with
hospital covariates added in one at a time to the model.
b Accessibility/Remoteness Index of Australia (ARIA+) based on hospital postcode.
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however, higher age-specific incidence of AMI particu-
larly among younger Aboriginal people was recently
reported by a study in Western Australia (WA) [8].
These findings and ours point to the importance of tar-
geting the early onset of AMI among Aboriginal people
and preventing or managing chronic diseases that may
complicate treatment or lead to poorer long-term
outcomes.
Our study found that once admitted to hospital, Abo-
riginal patients with AMI were less likely to die within
30 days than non-Aboriginal patients admitted to the
same hospital (Table 2, Model 1A). However, this finding
was explained by substantial age differences: after adjust-
ing for age, sex and year of admission, the differences in
30-day mortality was no longer significant (Model 2A).
In contrast, after adjusting for age, sex and year, Aborigi-
nal patients had 34% higher odds of dying within one
year compared with non-Aboriginal patients admitted to
the same hospital (Model 2B). However, this difference
was no longer significant after adjusting for selected
comorbidities (Model 3B), suggesting that part of the
higher one-year mortality is due to the higher comorbid-
ity burden among Aboriginal people admitted with AMI.
Our findings regarding short-term mortality differed
from those of the WA study, which reported higher post-
admission 28-day mortality ratios for Aboriginal compared
with non-Aboriginal patients, ranging from 1.7 in 55–74 year-old males and females to 3.6 in 25–54 year old
males [8]. This discrepancy might relate to the different
profile of the WA Aboriginal population (41% resident in
remote or very remote areas, compared with 5% in NSW)
[18], and differences in study methodology (the WA study
did not account for hospital of admission).
For longer-term mortality, our findings were similar to
those of a Queensland study that reported an age-
adjusted risk ratio of 1.8 (95% CI, 1.5-2.2) for 365-day
mortality in Aboriginal patients with AMI after admis-
sion to Queensland public hospitals [10]. We found that
the significantly higher one-year mortality for Aboriginal
patients did not persist after adjusting for comorbidities,
but a recent study in WA found significantly higher
rates of two-year cardiovascular death or recurrent AMI
for Aboriginal compared with non-Aboriginal males and
females after adjusting for demographic characteristics
and comorbidities [27]. These findings may suggest that
the Aboriginal to non-Aboriginal disparity in mortality
is greater in WA than in NSW. However, it is difficult to
compare these findings directly because our study had a
shorter length of follow-up for all-cause mortality,
adjusted for hospital of admission, and did not examine
mortality and recurrent AMI as a combined outcome.
An increase in the Aboriginal to non-Aboriginal mortal-
ity ratio with increasing time after discharge has been
shown in the Northern Territory for those admitted with
acute coronary syndrome and surviving to discharge,
Table 5 Relative odds of 30-day and 365-day mortality by different algorithms for identifying Aboriginal people in the
hospital data
30-day mortality 365-day mortality
AOR (95% CI) p-value AOR (95% CI) p-value
Most recenta
Non-Aboriginal (ref) 1.00 .684 1.00 .345
Aboriginal 0.95 0.73-1.23 1.11 0.90-1.36
Ever identifiedb
Non-Aboriginal (ref) 1.00 .582 1.00 .510
Aboriginal 0.94 0.74-1.18 1.06 0.88-1.28
All admissionsc
Non-Aboriginal (ref) 1.00 .005 1.00 <.001
Aboriginal 1.55 1.14-2.10 1.61 1.25-2.07
AOR, adjusted odds ratios, adjusting for age, sex, year of admission, comorbidities, remoteness of residence, socio-economic status.
CI, confidence interval. Ref, referent group in the analysis.
a Identified as Aboriginal in their most recent public hospital admission.
b Identified as Aboriginal in at least one public hospital admission.
c Identified as Aboriginal on all public hospital admissions.
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and Aboriginal patients being about three times more
likely to die than non-Aboriginal patients after four years
[28]. However, caution must be taken when comparing
Aboriginal peoples across Australia due to the differ-
ences in culture, geographic distribution, and access to
and provision of services.
Our study showed that differences between hospitals
impacted on mortality outcomes for both Aboriginal and
non-Aboriginal patients. After adjustment for patient fac-
tors, 2.72% of the remaining variation in 30-day mortality
was attributable to differences between hospitals. This
equates to a median odds ratio of 1.34, indicating a me-
dian difference of 34% in the odds of dying between ran-
domly chosen pairs of hospitals. Almost 40% of this
hospital-level contribution to variation in mortality was
explained by hospital remoteness, hospital size and cardiac
facilities. Patients admitted to smaller hospitals, and those
in outer regional and remote areas, had a higher risk of
short-term mortality, while patients admitted to a hospital
with on-site angiography facilities had a reduced risk of
dying. Recently, in the United States, condition-specific
hospital volume was shown to be related to 30-day post-
admission mortality after AMI, up to a threshold value,
which was lower for hospitals with cardiac revascularisa-
tion services (432 vs 586 AMI admissions/year) [29]. A
Canadian study also found that admission to hospitals
with on-site revascularisation facilities was related to
improved long-term outcomes after AMI [30]. However,
our findings regarding the specific impact of hospital size,
remoteness and on-site angiography facilities on outcomes
should be interpreted with caution, as these variables may
be correlated with other unmeasured aspects of hospitalquality of care. We found no variation in the Aboriginal to
non-Aboriginal mortality ratio (both short- and long-
term) across hospitals.
There were limitations to our study due to using ad-
ministrative data not collected for research purposes.
Firstly, there was limited clinical information in the hos-
pital data for risk adjustment; however, we used the con-
ditions adjusted for in the Ontario AMI Mortality Risk
Prediction Rule developed in Canada for use with AMI
and administrative hospital data [21] and supplemented
this with additional conditions from the Charlson
Comorbidity Index [22]. Secondly, we were not able to
remove all prevalent cases from our study because there
were only a total of eight and a half years of linked data
available. We did, however, test various clearance peri-
ods of up to four years and found that the Aboriginal to
non-Aboriginal age-and sex-adjusted mortality ratios did
not appear sensitive to the length of the clearance
period. Thirdly, our sensitivity analysis using different
algorithms for identifying Aboriginal people highlighted
the potential for apparent disparities to be influenced by
how Aboriginal status is defined. The strict definition re-
quiring patients to be identified as Aboriginal at every
hospital admission identified only 1% of admissions as
Aboriginal which is half as many as the ‘most recent’ al-
gorithm but generated higher relative odds of Aboriginal
mortality. This may be because those people consistently
identified as Aboriginal in the APDC have poorer health
than Aboriginal people not consistently identified, but it
may also be because the definition included a greater
proportion with only a single admission, possibly skew-
ing the sample towards people who died post-AMI.
Lastly, we did not include deaths from AMI that
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ther sudden death or death in ambulance or Emergency
Department. It is possible that Aboriginal people would
be overrepresented in these early deaths from AMI, due
to higher comorbidity rates or living a greater distance
from the nearest hospital, but this was outside the scope
of our study examining outcomes after hospital
admission.
Our study and others point to the importance of preven-
tion and early intervention to target the early onset of
AMI among Aboriginal Australians. These efforts must
target risk factor prevalence among Aboriginal people, in-
cluding higher rates of smoking and overweight and obes-
ity, and the earlier onset of comorbidities like diabetes and
renal failure [1]. However, poor health behaviours may be
a way of coping for people living under chronically stress-
ful conditions, so psychosocial and emotional factors must
also be taken into account [31,32]. Importantly, our study
has demonstrated that there are gains to be made—both
for Aboriginal and non-Aboriginal people—by improving
access to larger hospitals and hospitals with on-site angi-
ography or by improving the cardiac care facilities at smal-
ler hospitals.
The population density and geographic distances in
Australia pose difficult policy questions about whether it
is best to transfer patients as quickly as possible to major
city hospitals or whether it is efficient to increase ser-
vices in less densely population areas. Our results
showed that the difference in outcomes for inner re-
gional compared with major city hospitals was small and
not significant, so boosting resources in regional centres
may reduce the difference altogether, and reduce travel
times to cardiac facilities for those living in regional and
remote areas. One challenge is to ensure that any inter-
ventions are culturally appropriate for Aboriginal
patients. While transfers can be very stressful for Abori-
ginal people living in remote areas, an action research
study concluded that small interventions such as having
dedicated liaison officers in the health system could im-
prove cultural awareness of practitioners as well as com-
munication and continuity of care and improve outcomes
for Aboriginal patients [33].
The higher mortality among Aboriginal patients in the
first year after admission also highlights the importance
of improved post-AMI care including appropriate medi-
cation and lifestyle interventions. This period after dis-
charge warrants further investigation to disentangle the
impacts on mortality of comorbidity burden and differ-
ences in access to, or adherence with, follow-up care
and secondary prevention.
Conclusions
Improving access to larger hospitals or those with special-
ist treatment facilities could improve outcomes followingAMI for residents of rural and regional areas, both Abori-
ginal and non-Aboriginal. However, major efforts to boost
primary and secondary prevention of AMI are required to
reduce the mortality gap between Aboriginal and non-
Aboriginal people.
Competing interests
The authors declare that they have no competing interest.
Authors’ contributions
DR had overall responsibility for the design of this study, data management,
statistical analysis and drafting this paper. LJ initiated the IHOPE project and
provided overall oversight. LJ, SL, TC, MH, SE and AL contributed to the
conception and design of the IHOPE project. SL provided advice on data
management and statistical analysis. AO provided advice on clinical aspects
and on hospital levels of service. AL provided oversight and advice for the
design and interpretation of the statistical analyses. All authors contributed
to the interpretation of findings, the writing of the paper and approved the
final draft.
Acknowledgements
We would like to acknowledge the NSW Ministry of Health and NSW
Register of Births, Deaths and Marriages for allowing access to the data, and
the Centre for Health Record Linkage for conducting the probabilistic linkage
of records. We would also like to thank the reviewers for their thoughtful
comments on earlier drafts of this paper. The Indigenous Health Outcomes
Patient Evaluation (IHOPE) study is funded by a National Health and Medical
Research Council Project Grant (#573113). The funding body had no role in
the research project.
Author details
1School of Medicine, University of Western Sydney, Narellan Road,
Campbelltown, NSW, Australia. 2The Sax Institute, Quay Street, Sydney, NSW,
Australia. 3Baker IDI Heart and Diabetes Institute, Commercial Road,
Melbourne, Victoria, Australia. 4Medical Research Council/Chief Scientist
Office Social and Public Health Sciences Unit, Lilybank Gardens, Glasgow, UK.
Received: 17 October 2011 Accepted: 3 April 2012
Published: 10 April 2012
References
1. Australian Institute of Health and Welfare, Australian Bureau of Statistics: The
Health and Welfare of Australia’s Aboriginal and Torres Strait Islander Peoples,
2008. Canberra, Australia: Australian Institute of Health and Welfare and
Australian Bureau of Statistics; 2008.
2. Vos T, Barker B, Begg S, Stanley L, Lopez AD: Burden of disease and injury
in Aboriginal and Torres Strait Islander Peoples: the Indigenous health
gap. Int J Epidemiol 2009, 38:470–477.
3. Thomson N, Ride K: Summary of the cardiovascular health status of
Indigenous peoples. [accessed 17 June 2011]; [http://www.healthinfonet.
ecu.edu.au/chronic-conditions/cvd/reviews/our-review.]
4. Hayman NE, White NE, Spurling GK: Improving Indigenous patients’ access
to mainstream health services: the Inala experience. Med J Aust 2009,
190:604–606.
5. Turrell G, Kavanagh A, Draper G, Subramanian SV: Do places affect the
probability of death in Australia? A multilevel study of area-level
disadvantage, individual-level socioeconomic position and all-cause
mortality, 1998–2000. J Epidemiol Community Health 2007, 61:13–19.
6. Hill K, Barker B, Vos T: Excess indigenous mortality: are indigenous
Australians more severely disadvantaged than other Indigenous
populations? Int J Epidemiol 2007, 36:580–589.
7. Mathur S, Moon L, Leigh S: Aboriginal and Torres Strait Islander people with
coronary heart disease: further perspectives on health status and treatment.
Canberra, Australia: Australian Institute of Health and Welfare; 2006.
8. Katzenellenbogen JM, Sanfilippo FM, Hobbs MST, Briffa TG, Ridout SC,
Knuiman MW, Dimer L, Taylor KP, Thompson PL, Thompson SC: Incidence
of and case fatality following acute myocardial infarction in Aboriginal
and non-Aboriginal Western Australians (2000–2004): a linked data
study. Heart Lung Circ 2010, 19:717–725.
Randall et al. BMC Public Health 2012, 12:281 Page 11 of 11
http://www.biomedcentral.com/1471-2458/12/2819. Brown A: Acute coronary syndromes in Indigenous Australians:
opportunities for improving outcomes across the continuum of care.
Heart Lung Circ 2010, 19:325–336.
10. Coory MD, Walsh WF: Rates of percutaneous coronary interventions and
bypass surgery after acute myocardial infarction in Indigenous patients.
Med J Aust 2005, 182:507–512.
11. Bradshaw PJ, Alfonso HS, Finn J, Owen J, Thompson PL: The use of
coronary revascularisation procedures in urban Australian Aboriginals
and a matched general population: coronary procedures in Aboriginals.
Heart Lung Circ 2010, 19:247–250.
12. National Centre for Classification in Health: International Statistical
Classification of Diseases and Related Health Problems, 10th Revision,
Australian Modification (ICD-10-AM), Australian Classification of Health
Interventions (ACHI) and Australian Coding Standards (ACS). 5th edition.
Sydney: National Centre for Classification in Health; 2006.
13. Centre for Health Record Linkage [http://www.cherel.org.au]
14. Australian Bureau of Statistics: 3238.0.55.001 - Experimental Estimates of
Aboriginal and Torres Strait Islander Australians, Jun 2006. Canberra, Australia:
ABS; 2008 [accessed September 17 2010]; [http://www.abs.gov.au/ausstats/
abs@.nsf/Latestproducts/3238.0.55.001Main%20Features1Jun%202006?
opendocument&tabname=Summary&prodno=3238.0.55.001&issue=Jun%
202006&num=&view=]
15. Population Health Division: The health of the people of New South Wales -
Report of the Chief Health Officer. Sydney. NSW Department of Health; 2006
[accessed 7 April 2011]; [http://www.health.nsw.gov.au/publichealth/
chorep/rur/rur_pop_aria_atsi.asp]
16. Australian Bureau of Statistics: 4705.0 Population distribution, Aboriginal and
Torres Strait Islander Australians. Canberra, Australia: ABS; 2006 [accessed 31
March 2011]; [http://www.ausstats.abs.gov.au/ausstats/subscriber.nsf/0/
377284127F903297CA25733700241AC0/$File/47050_2006.pdf]
17. Australian Bureau of Statistics. 3238.0 - Experimental Estimates and
Projections, Aboriginal and Torres Strait Islander Australians, 1991 to 2021.
Canberra, Australia: ABS; 2009 [accessed 14 March 2012]; [http://www.abs.
gov.au/ausstats/abs@.nsf/0/DDAB99776D7ABDC7CA25762A001CC066?
opendocument]
18. Australian Bureau of Statistics. 3235.0 - Population by age and sex, Australia,
2006. Canberra, Australia: ABS; 2007 [accessed 14 March 2012]; [http://www.
abs.gov.au/ausstats/abs@.nsf/Products/3235.0~2006~Main+Features~New
+South+Wales?OpenDocument]
19. Australian Institute of Health and Welfare: Indigenous identification in
hospital separations data - quality report. Canberra, Australia: Australian
Institute of Health and Welfare; 2010.
20. Australian Institute of Health and Welfare: Improving the quality of
Indigenous identification in hospital separations data. Canberra, Australia:
Australian Institute of Health and Welfare; 2005.
21. Vermeulen MJ, Tu JV, Schull MJ: ICD-10 adaptations of the Ontario acute
myocardial infarction mortality prediction rules performed as well as the
original versions. J Clin Epidemiol 2007, 60:971–974.
22. Sundararajan V, Henderson T, Perry C, Muggivan A, Quan H, Ghali WA: New
ICD-10 version of the Charlson comorbidity index predicted in-hospital
mortality. J Clin Epidemiol 2004, 57:1288–1294.
23. Leyland AH, Groenewegen PP: Multilevel modelling and public health
policy. Scand J Public Health 2003, 31:267–274.
24. Merlo J, Chaix B, Ohlsson H, Beckman A, Johnell K, Hjerpe P, Råstam L,
Larsen K: A brief conceptual tutorial of multilevel analysis in social
epidemiology: using measures of clustering in multilevel logistic
regression to investigate contextual phenomena. J Epidemiol Community
Health 2006, 60:290–297.
25. SAS Institute Inc: SAS Version 9.1.3 [software]. Cary, North Carolina: SAS; 2003.
26. Rasbash J, Browne WJ, Healy M, Cameron B, Charlton C: MLwiN Version 2.22
[software]. Bristol: Centre for Multilevel Modelling, University of Bristol; 2010.
27. Katzenellenbogen JM, Sanfilippo FM, Hobbs MST, Briffa TG, Ridout SC,
Knuiman MW, Dimer L, Taylor KP, Thompson PL, Thompson SC: Aboriginal
to non-Aboriginal differentials in 2-year outcomes following non-fatal
first-ever acute MI persist after adjustment for comorbidity. Eur J
Cardiovasc Prev Rehabil [published online ahead of print 28 July 2011].
28. Brown A: Bridging the survival gap between Indigenous and non-
Indigenous Australians: priorities for the road ahead. Heart Lung Circ
2009, 18:96–100.
29. Ross JS, Normand SLT, Wang Y, Ko DT, Chen J, Drye EE, Keenan PS,
Lichtman JH, Bueno H, Schreiner GC, Krumholz HM: Hospital volume and30-day mortality for three common medical conditions. N Engl J Med
2010, 362:1110–1118.
30. Alter DA, Naylor CD, Austin PC, Tu JV: Long-term MI outcomes at hospitals
with or without on-site revascularization. JAMA 2001, 285:2101–2108.
31. Wood L, France K, Hunt K, Eades S, Slack-Smith L: Indigenous women and
smoking during pregnancy: knowledge, cultural contexts and barriers to
cessation. Soc Sci Med 2008, 66:2378–2389.
32. Mezuk B, Rafferty JA, Kershaw KN, Hudson D, Abdou CM, Lee H, Eaton WW,
Jackson JS: Reconsidering the role of social disadvantage in physical and
mental health: stressful life events, health behaviors, race, and
depression. Am J Epidemiol 2010, 172:1238–1249.
33. Lawrence M, Dodd Z, Mohor S, Dunn S, de Crespigny C, Power C, MacKean
L: Improving the Patient Journey: Achieving Positive Outcomes for Remote
Aboriginal Cardiac Patients. Darwin, Australia: Cooperative Research Centre
for Aboriginal Health, Darwin; 2009.
doi:10.1186/1471-2458-12-281
Cite this article as: Randall et al: Mortality after admission for acute
myocardial infarction in Aboriginal and non-Aboriginal people in New
South Wales, Australia: a multilevel data linkage study. BMC Public Health
2012 12:281.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
